IGF2BP2 and cancer: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) is associated with a worse prognosis in patients with OSCC by regulating cancer-related biological pathways, such as glycolysis, epithelial-mesenchymal transition, and the cell cycle [28].